ICB INTERNATIONAL
Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a proprietary blood-brain barrier (BBB) permeable technology to address issues relating to the diseases of the central nervous system (CNS). This platform technology is now being leveraged to develop FDA (Food and Drug Administration) approved non-invasive diagnostics and therapeutics for neurodegenerative, cancer, and infectious diseases.
ICB INTERNATIONAL
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2008-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.icbii.com
Total Employee:
1+
Status:
Active
Contact:
8587552907
Email Addresses:
[email protected]
Total Funding:
895 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Official Site Inspections
http://www.icbii.com
- Host name: 107.223.169.192.host.secureserver.net
- IP address: 192.169.223.107
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ICB International"
About – ICBI - icbii.com
With her near three decades of experience as President and Executive Director of Parkinson’s Resource Organization, Ms. Rosen personally met the challenges of Parkinson’s with her late …See details»
ICB International - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 8587552907 Innovative California Biosciences International, Inc.,('ICBI'), an immunology and biomedicine company, has developed a …See details»
ICBI Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ICBI. Use the PitchBook Platform to explore the full profile.See details»
Investor Section – ICBI - icbii.com
Inquiries regarding investments and licensing may be directed to: 1. Ranya Alexander, COO, PhD, MD Email: [email protected] Tel: 1-858-455-9880See details»
ICBII UPDATE ON THE ROAD TO THE CURE (May 2022)
Apr 28, 2022 ICB International, Inc., (“ICBII”), a La Jolla, CA, based biopharmaceutical company decided early on not to do what most of the pharmaceutical companies have been following for …See details»
ICB International - Products, Competitors, Financials, Employees ...
Crypto Asset Rating Announces ICBII, A Biotech Company, is launching Digital Securities on the Tokenization Asset Platform. Aug 16, 2021. Tokenization Asset Platform (TAP) is delighted to …See details»
ICB International - Craft
ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system (CNS). Its SMART molecule technology platform enables the …See details»
ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier ...
Sep 23, 2021 ABOUT ICBII: The Company was founded for the sole purpose of addressing unmet therapeutic needs for central nervous system and difficult to cure cancer diseases. The …See details»
ICBII Update on the Road to the Cure (February, 2022)
Jan 31, 2022 Please contact ICBI directly through their website ICBII.com or by phone 858-455-9880. IMAGINE the world without Parkinson’s, MSA, or Alzheimer’s disease. ... Parkinson's …See details»
ICBII UPDATE ON THE ROAD TO THE CURE - JANUARY 2023
Jan 1, 2023 The joy of being a part of these historical events can be had by helping ICBII find the funds to bring these trials to fruition through your investing, and by finding others with the …See details»
Employment – ICBI - icbii.com
ICB International, Inc., (“ICBII”), La Jolla, California is dedicated to developing disease altering therapies for diseases of the central nervous system (CNS) to ameliorate the sufferings of …See details»
Recommended Stories - Yahoo Finance
Jun 9, 2015 BEVERLY HILLS, CA / ACCESSWIRE / June 9, 2015 / ICB International Inc., ("ICBI or ICBII"), launches Blood-Brain Barrier crossing SMART Molecule platform technology and …See details»
ICBII Update on the Road to the Cure - August 2022
Jul 28, 2022 Please contact ICBII directly through their website ICBII.com or by phone 858-455-9880. IMAGINE the world without Parkinson’s, MSA, or Alzheimer’s disease. JUST IMAGINE. …See details»
Contact – ICBI - icbii.com
Come & Visit Us. 505 Coast Blvd South, #405 La Jolla, CA 92037, USA. Give Us A Call +1-858-455-9880See details»
ICBII Update on the Road to the Cure - April 2022
Mar 31, 2022 Parkinson's Resource Organization 74785 Highway 111 Suite 208 Indian Wells, CA 92210. Local Phone (760) 773-5628. Toll-Free Phone (877) 775-4111. General …See details»
ICBI, Inc. - Facebook
ICBII is a development-stage biotechnology company. Its biologics specifically target pathologic proteins in the central nervous system, offering clinical... ICBI, Inc. 869 likes · 1 talking about this. ICBII is a development-stage …See details»
Press Releases – ICBI - icbii.com
Dec 18, 2018 La Jolla, California, USA, Innovative California Biosciences International, Inc., (“ICBII”), announced on December 21, 2018… admin December 18, 2018 ICBII Announces …See details»
ICBII Update on the Road to the Cure - Parkinson's Resource …
May 31, 2022 Therefore, ICBII has the technology to potentially diagnose Parkinson’s disease long before the symptoms appear, which no one else can do. ... Parkinson's Resource …See details»
News – ICBI - icbii.com
Sep 22, 2021 La Jolla, California, USA, Innovative California Biosciences International, Inc., (“ICBII”), announced on December 21, 2018… admin December 18, 2018 ICBII Announces …See details»